Topic: The Latest Research Progress of Nonalcoholic Fatty Liver Disease
A Special Issue of Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)
Submission deadline: 31 Oct 2023
Guest Editor(s)
Special Issue Introduction
Nonalcoholic fatty liver disease (NAFLD), the most common cause of chronic liver disease worldwide, is a multisystem disease associated with hepatic and extrahepatic complications. NAFLD is strongly associated with an increased risk of fatal and nonfatal cardiovascular events. No standardized pharmacotherapy against NAFLD is available and several ongoing clinical trials are exploring new drugs. The Special Issue aims to highlight the most recent advances in the diagnosis and management of NAFLD. Potential topics to be discussed in this issue include new developments in:
● Disease definition;
● Pathogenesis;
● Diagnosis and risk stratification;
● Anti-inflammatory, anti-metabolic, and anti-fibrotic therapies;
● Non-invasive markers of treatment efficacy;
● Management of lean vs. obese NAFLD.
Submission Deadline
Submission Information
For Author Instructions, please refer to https://www.oaepublish.com/mtod/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=mtod&SpecialIssueId=mtod230424
Submission Deadline: 31 Oct 2023
Contacts: Leah Leah, Managing Editor, leah@oaemesas.com
